FDAFDA recall Z-2921-2026 · Aug 19, 2026
Covidien, LP: Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623 recall
Quick answer
- Product
- Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623
- Brand
- Covidien, LP
- Codes, lots and dates
- SP-623 UDI-DI 20884521037073 Lot D6A2963Y
- Hazard
- Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
- Distribution
- US Nationwide and the countries of Australia, Austria, Belgium, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guadeloupe, Guatemala, Honduras, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Kosovo, Lebanon, Lithuania, Luxembourg, Mexico, Namibia, Netherlands, North Macedonia, Northern Ireland, Norway, Oman, Panama, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan.
- Quantity
- 135,875 total
- Recall date
- Aug 19, 2026
- Agency
- U.S. Food and Drug Administration (FDA) enforcement report
- Recall number
- Z-2921-2026
Recall found
Product
Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623
Reason for recall
Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
| Quantity | 135,875 total |
|---|---|
| Codes, lots and dates | SP-623 UDI-DI 20884521037073 Lot D6A2963Y |
| Distribution | US Nationwide and the countries of Australia, Austria, Belgium, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guadeloupe, Guatemala, Honduras, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Kosovo, Lebanon, Lithuania, Luxembourg, Mexico, Namibia, Netherlands, North Macedonia, Northern Ireland, Norway, Oman, Panama, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan. |
| Recall date | Aug 19, 2026 |
| Class | Class II |
| Agency ID | Z-2921-2026 |
| Official notice | U.S. Food and Drug Administration (FDA) enforcement report |
| Data as of, last checked | Nov 21, 2026, 3:48 PM EST |
Recall details
- FDA classification
- Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
- Status
- Ongoing
- Codes, lots and dates
- SP-623 UDI-DI 20884521037073 Lot D6A2963Y
- Quantity
- 135,875 total
- Distribution
- US Nationwide and the countries of Australia, Austria, Belgium, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guadeloupe, Guatemala, Honduras, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Kosovo, Lebanon, Lithuania, Luxembourg, Mexico, Namibia, Netherlands, North Macedonia, Northern Ireland, Norway, Oman, Panama, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan.
- Recalling firm
- Covidien, LP, North Haven, CT
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-06-24
Source: openFDA enforcement record Z-2921-2026 · search recall number Z-2921-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Nov 21, 2026, 3:48 PM EST. The agency notice is the final word.
FAQ
What was recalled?
Product: Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623 Brand: Covidien, LP Codes, lots and dates: SP-623 UDI-DI 20884521037073 Lot D6A2963Y
What is the hazard?
Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
How do I check if mine is affected?
Codes, lots and dates: SP-623 UDI-DI 20884521037073 Lot D6A2963Y
Where was it distributed?
US Nationwide and the countries of Australia, Austria, Belgium, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guadeloupe, Guatemala, Honduras, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Kosovo, Lebanon, Lithuania, Luxembourg, Mexico, Namibia, Netherlands, North Macedonia, Northern Ireland, Norway, Oman, Panama, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan.
Related recalls
- Covidien, LP: Dermalon 88861757-31 DERMALON* 4-0 BLU 75CM C13 88861757-31 88861799-31 DERMALON* 4-0 BLU recall
- Covidien, LP: V-Loc 90 Absorbable Wound Closure Device VLOC 90 0 VL 22 GS-21 VLOCM0336 VLOC 90 0 VL 22 G recall
- Covidien, LP: Surgipro II S8698GX SURGIPRO II BL 5/0 18 P-13 S8698GX recall
- Covidien, LP: V-Loc 180 Absorbable Wound Closure Device BOX BEDSIDE STAPLING IS KING BOX06614V4 BOX BY P recall
- Greenwich: Compounded sterile products
- Breckenridge Pharmaceutical, Inc.: Propranolol Hydrochloride Extended-Release Capsules, USP, 60mg
